Interaction of amiodarone and triiodothyronine on the expression of β-adrenoceptors in brown adipose tissue of rat

British Journal of Pharmacology

Volumn 126, Issue 6, 1999, Pages 1455-1461

  Adli, Houria ^a,c   Bazin, Raymond ^b   Perret, Gérard Y ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c INSERM   (France)

Author keywords

Adenylyl cyclase; ADP ribosylation; Amiodarone; Brown adipose tissue; CGP 12177; G proteins; Triiodothyronine; 1 and 3 adrenoceptors

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ADENYLATE CYCLASE; AMIODARONE; BETA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LIOTHYRONINE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROIDECTOMY;

EID: 0033032315     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702456     Document Type: Article

References (41)

1. ADLI, H., BAZIN, R., VASSY, R. & PERRET, G.Y. (1997). Effects of triiodothyronine administration on the adenylyl cyclase system in brown adipose tissue of rat. Am. J. Physiol., 36, E247-E253.
2. BAHOUTH, S.W. (1991). Thyroid hormones transcriptionally regulate the β-adrenergic receptor gene in cultured ventricular myocytes. J. Biol. Chem., 266, 15863-15869.
3. BAKKER, O., VAN BEEREN, H.C. & WIERSINGA, W.M. (1994). Desethylamiodarone is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone β1 receptor protein. Endocrinology, 134, 1665-1670.
4. BOUYARD, P. & JADOT, G. (1977). Thyroïdectomie total chez le rat. J. Pharmacol., 8, 115-119.
5. BURGER, A., DINICHERT, D., NICOD, P., LE MARCHAND-BERAUD, T. & VALLOTON, M.B. (1976). Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxine and thyrotropin. J. Clin. Invest., 58, 255-259.
6. CEPPI, J.A. & ZANINOVICH, A.A. (1989). Effects of amiodarone on 5′-deiodination of thyroxin to triiodothyronine in rat myocardium. J. Endocrinol., 121, 431-434.
7. CHARON, C., KRIEF, S., DUPUY, F., STROSBERG, A.D., EMORINE, L.J. & BAZIN, R. (1995). Early alterations in the brown adipose tissue adenylate cyclase system of pre-obese Zuker rat fa/fa pups: Decreased G-proteins and β3-adrenoceptor activities. Biochem. J., 312, 781-786.
8. CHAUDRY, A., MACKENZIE, R.G., GEORGIC, L.M. & GRANNEMAN, G. (1994). Differential interaction of β1- and β3-adrenergic receptors with Gi in rat adipocytes. Cell. Signal., 6, 457-465.
9. DISATNIK, M.H. & SHAINBERG, A. (1991). Regulation of βadrenoceptors by thyroid hormone and amiodarone in rat myocardiac cells in culture. Biochem. Pharmacol., 41, 1039-1044.
10. DRVOTA, V., CARLSSON, B., HAGGBLAD, J. & SYLVEN, C. (1995). Amiodarone is a dose-dependent non competitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype β1, whereas disopyramide, lignocaine, propafenone, metoprolol, dl-sotalol and verapamil have no inhibitory effect. J. Cardiovasc. Pharmaeol., 26, 222-226.
11. DUSSAILLANT, G., JALIL, J.E. & CESPEDES, C. (1994). Amiodarone protection against myocardial injury and fibrosis induced by isoprenaline is abolished by thyroid hormone. Cardiovasc. Res., 28, 1008-1013.
12. FRANKLYN, J.A., GAMMAGE, M.D. & SHEPPARD, M.C. (1987). Amiodarone and thyroid hormone effects on anterior pituitary hormone gene expression. Clin. Endocrinol., 27, 373-382.
13. GERMACK, R., ADLI, H., VASSY, R. & PERRET. G.Y. (1996). Triiodothyronine and amiodarone effects pm β3-adrenoceptor density and lipolytic response to the β3-adrenergic agonist BRL 37344 in rat white adipocytes. Fundam Fundain. Clin. Pharmacol., 10, 289-297.
14. GIACOBINO, J.P. (1979). Subcellular fractionation of brown adipose tissue. J. Supramol. Struct., 11, 445 449.
15. GRANNEMAN, J.G. & LAHNERS, K.N. (1992). Differential adrenergic regulation of β1 and β3 adrenoceptor messenger ribonucleic acids in adipose tissues. Endocrinology, 130, 109-114.
16. GRANNEMAN, J.G. & MACKENZIE, R.G. (1988). Neural modulation of the stimulatory regulatory protein of adenylate cyclase in rat brown adipose tissue. J. Pharmacol. Exp. Ther., 245, 1068-1074.
17. HARTONG, R., WIERSINGA, W.M., LAMERS, W.H., PLOMP, T.A., BROENINK, M. & VAN BEEN, M.H. (1987). Effects of amiodarone on thyroid hormone-responsive gene expression in rat liver. Harm. Metab. Res., 17, 34-43.
18. HARTONG, R., WIERSINGA, W.M. & PLOMP, T.A. (1990). Amiodarone reduces the effect of T3 on beta adrenergic receptor density in rat heart. Horm. Metab. Res., 22, 85-90.
19. KAUMANN, A.J. & MOLNAAR, P. (1996). Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat. Br. J. Pharmacol., 118, 2085-2098.
20. LANGIN, D., PORTILLO, M.P., SAULNIER-BLANCHE, J.P. & LAFONTON, M. (1991). Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species. Eur. J. Pharmacol., 199, 291-301.
21. LATHAM, K.R., SELLITTI, D.F., GOLDSTEIN, R.E. & FACC, M.D. (1987). Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors. J. Am. Coll. Cardiol., 9, 872-876.
22. 3H]CGP-12177, generally classified as an antagonist, is a thermogenic agonist in brown adipose tissue. Biochem. J., 261, 401-405.
23. MUZZIN, P., REVELLI, J.P., FRASERT, C.M. & GIACOBINO, J.P. (1992). Radioligand binding studies of the atypical β3-adrenergic receptor in rat brown adipose tissue using [3H]CGP 12177. FEBS Lett., 298, 162-164.
24. NAHMIAS, C.N., BLIN, J.M., ELALOUF, M., MATTEI, G., STROSBERG, A.D. & EMORINE, L.J. (1991). Molecular characterization of the mouse β3-adrenergic receptor: Relationship with the atypical receptor of adipocytes. Eur. Mol. Biol. Organ. J., 10, 3721-3727.
25. NOKIN, P., CLINET, M. & SCHOENFELD, P. (1983). Cardiac βadrenoceptor modulation by amiodarone. Biochem. Pharmacol., 32, 2473-2477.
26. NORMAN, M.F. & LAVIN, T. (1989). Antagonism of thyroid hormone action by amiodarone in rat pituitary tumour cells. J. Clin. Invest., 83, 306-313.
27. PARADIS, P., LAMBERT, C. & ROULEAU, J. (1991). Amiodarone antagonizes the effects of T3 at the receptor level: An additional mechanism for its in vivo hypothyroid-like effects. Can. J. Physiol. Pharmacol., 69, 865-870.
28. PEKARY, A.E., HERSHMAN, J.M., REED, A.W., KANNON, R. & WANG, Y.S. (1986). Amiodarone inhibits T4 to T3 conversion and α-glycerophosphate dehydrogenase and malic enzyme levels in rat liver. Horm. Metab. Res., 18, 114-118.
29. PERRET, G., YIN, Y.L., NICOLAS, P., PUSSARD, E., VASSY, R., UZZAN, B. & BERDEAUX, A. (1992). Amiodarone decreases cardiac fl-adrenoceptors through an antagonistic effect on 3,5,3' triiodothyronine. J. Cardiovasc. Pharmacol., 19, 473-478.
30. PLOMP, T.A., WIERSINGA, W.M. & MAES, R.A. (1985). Tissue distributions of amiodarone and desethylamiodarone in rats after multiple intraperitoneal administration of various amiodarone doses. Arzneim. Forsch., 35, 122-129.
31. PREITNER, F., MUZZIN, P., REVELLI, J.P., SEYDOUX, J., GALITZKY, J., BERLAN, M., LAFONTON, M. & GIACOBINO, J.P. (1998). Metabolic response to various fl-adrenoceptor agonists in β3-adrenoceptor knockout mice. Evidence for a new fl-adrenergic receptor in brown adipose tissue. Br. J. Pharmacol., 124, 1684-1688.
32. REVELLI, J.P., PESCINI, R., MUZZIN, P. & SEYDOUX, J. (1991). Changes in β1- and β2-adrenergic receptor mRNA levels in brown adipose tissue and heart of hypothyroid rats. Biochem. J., 277, 625-629.
33. ROTHWELL, N.J., STOCK, M.J. & SUDERA, D.K. (1985). Changes in adrenoceptor density in brown adipose tissue from hyperthyroid rats. Eur. J. Pharmacol., 114, 227-229.
34. RUBIO, A., RAASMAJA, A. & SILVA, J.E. (1995a). Thyroid hormone and norepinephrine signaling in brown adipose tissue. II: Differential effects of thyroid hormone on β3-adrenergic receptors in brown and white adipose tissue. Endocrinology, 136, 3277-3284.
35. RUBIO, A., RAASMAJA, A., MARIA, A.L., KIMM, K. & SILVA, J.E. (1995b). Effects of thyroid hormone on norepinephrine signaling in brown adipose tissue I. β1- and β2-adrenergic receptors and cyclic adenosine 3,5'-monophosphate generation. Endocrinology, 136, 3267-3276.
36. SINGH, B.N. & VAUGHAN-WILLIAMS, E.M. (1970). The effect of amiodarone, a new antianginal drug, on cardiac muscle. Br. J. Pharmacol., 39, 657-667.
37. SOGOL, P.B., HERSHMAN, J.M., REED, A.W. & DILLMAN, W.H. (1983). The effects of amiodarone on serum thyroid hormones and hepatic thryoxin 5′-monodeiodination in rats. Endocrinology, 113, 1464-1469.
38. STAEHELIN, M., SIMONS, P., JAEGGI, K. & WIGGER, N. (1983). CGP-12177 a hydrophilic β-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J. Biol. Chem., 258, 3496-3502.
39. TALAJIC, M., NATTEL, S., DAVIES, M. & MCCANS, J. (1989). Attenuation of class 3 and sinus node effects of amiodarone by experimental hypothyroidism. J. Cardiovas. Pharmacol., 13, 447-450.
40. VAN BEEREN, H.C., BAKKER, O. & WIERSINGA, W.M. (1995). Desethylamiodarone is a competitive inhibitor of the binding of thyroid hormone to thyroid hormone α1-receptor protein. Mol. Cell. Endocrinol., 112, 15-19.
41. YIN, Y.L., PERRET, G.Y., NICOLAS, P., VASSY, R., UZZAN, B. & TOD, M. (1992). In vivo effects of amiodarone on cardiac βadrenoceptor density and heart rate require thyroid hormones. J. Cardiovasc. Pharmacol., 19, 541-545.